News DeepTechU Day 3: Navigating Lab to Launch, Deep Tech Investment, and a Culture Shift Toward Commercialization “The best companies we see have deep venture experience,” said Beckett Jackson, investing director, Boeing HorizonX. But they also have a grand vision about how the technology will become a...
Page Venture Gallery Venture Gallery View startups founded from across the University of Chicago ecosystem in a range of industries. Welcome to the Venture Gallery! The Polsky Center provides “first look” and early...
Program UChicago Private Markets Program Explore careers in private markets through workshops, theory, case studies, and networking opportunities.
Technology Fully Synthetic Adjuvant Delivery System For Enhanced Tumor-Targeted Immunotherapy A cancer vaccine that enhances immune response by directly binding adjuvants to tumor cells, avoiding targeting antibodies, and reducing related side effects The problem: Therapeutic vaccination has long been a…
Technology Protein Engineering Strategy for Enhancing Healing Of Chronic Diabetic and Radiation-Induced Wounds The problem: Chronic, non‐healing wounds have reached epidemic proportions and have a sustainable impact on both an individual’s quality of life and on healthcare costs as a whole The field…
Technology Development Of A Novel Anti-fibrotic (siRNA Talin2) That Reverses Existing Fibrosis Fibrosis is involved in 45% of deaths in the United States, and no treatment exists to reverse the progression of the disease. Fibrosing diseases include pulmonary fibrosis, congestive heart failure,…
News ISTC Releases 2020 R&D Index and Names Three UChicago Professors Top Researchers to Know The Illinois Science and Technology Coalition (ISTC) this week released its latest R&D Index – as well as this year’s Researchers to Know, which includes three faculty members from the...
Technology RNA Editing Technology for Enhancing Tumor Immunogenicity and Immune Checkpoint Inhibitors Novel RNA editing method to generate a multitude of neoantigens in tumor cells making the cells more recognizable by T cells and enhancing the efficacy of immune checkpoint inhibitors The…
Technology Engineered Flt3L Variants For Antigen Tolerance Induction Engineered recombinant fusion of the dendritic cell growth factor Flt3L to serum albumin to modulate the antigen-presenting compartment and bias it toward tolerance particularly against therapeutic proteins. The Unmet Need:…
News Meet the Investor: Jeffrey Stine, VestedWorld “We are very excited about what we call “tech-enabled” solutions, and Africa, in my view, is ground zero for these types of opportunities.” That is according to Jeffrey Stine, principal...
Event Entrepreneurship Essentials (E2): How Startups Miss Their Market and How to Avoid it with Jeff Berman (Part 1 of 2) February 10, 2026 Join the Polsky Center and Jeff Berman for an informative workshop on how startups miss their market. Participants will learn how to validate demand, identify customers who actually care, and...
Event Entrepreneurship Essentials (E2): How Startups Miss Their Market and How to Avoid it with Jeff Berman (Part 2 of 2) February 11, 2026 Join the Polsky Center and Jeff Berman to discuss how attention works, how to create a compelling message, and how to build upon early success to gain real market traction....
